Bayer Schering inks Singapore cancer research pact
This article was originally published in Scrip
Executive Summary
Bayer Schering Pharma (BSP) is to collaborate with the National University of Singapore to conduct preclinical research in oncology. The deal is the second between a pharma multinational and the island state's national research facilities in the past few months.